Text Size

Retrospective Treatment Pattern Survey for the Patients With Hypertension and Stroke (SAPPHIRE)

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00681707
First received: May 19, 2008
Last updated: July 8, 2009
Last verified: July 2009
History of Changes
  Purpose

This study will address the treatment rate and control rate of hypertension, treatment pattern and factors that affect BP control by examining retrospective medical records of hypertension patients recovering from stroke, among outpatients coming to the Neurology Department in 10 university hospitals nationwide.


Condition
Hypertension

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: A Retrospective, Multi Centre, Non-Interventional, Observational Study to Investigate Treatment Pattern of Blood Pressure in the Post Stroke Patients With Hypertension.

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Attainment rate to the target blood pressure [ Time Frame: After collecting all Patient Record Form. ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Dropout rate will be estimated during the follow-up period after the hypertension treatment. Attainment to the target blood pressure will be investigated according to concomitant diseases. [ Time Frame: After collecting all Patient Record Form. ] [ Designated as safety issue: No ]
  • Change in DBP/SBP value during the follow-up period will be addressed. Change in the DBP/SBP value will be investigated according to the risk factors and concurrent disease. [ Time Frame: After collecting all Patient Record Form. ] [ Designated as safety issue: No ]

Estimated Enrollment: 1000
Study Start Date: May 2008
Study Completion Date: July 2008
Groups/Cohorts
1
Hypertension patients recovering from stroke

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patient with history of stroke, receiving hypertension medication during at least 1 year.

Criteria

Inclusion Criteria:

  • Patients had been hospitalized as a acute stroke in 2006
  • Patient with history of stroke receiving hypertension medication during at least 1 year.

Exclusion Criteria:

  • Secondary hypertension patients
  • Patients not receiving hypertension medication
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00681707

Locations
Korea, Republic of
Research Site
Goyang, Gyeonggi, Korea, Republic of
Research Site
Sungnam, Gyeonggi, Korea, Republic of
Research Site
Wonju, Kangwon, Korea, Republic of
Research Site
Busan, Korea, Republic of
Research Site
Deagu, Korea, Republic of
Research Site
Deajeon, Korea, Republic of
Research Site
Kwangju, Korea, Republic of
Research Site
Seoul, Korea, Republic of
Sponsors and Collaborators
AstraZeneca
Investigators
Study Director: Joon Woo Bahn Astrazenca Korea medical dept.
  More Information

No publications provided

Responsible Party: Joonwoo Bahn, AstraZeneca
ClinicalTrials.gov Identifier: NCT00681707     History of Changes
Other Study ID Numbers: NIS-CKR-DUM-2008/1
Study First Received: May 19, 2008
Last Updated: July 8, 2009
Health Authority: Korea: Food and Drug Administration

Keywords provided by AstraZeneca:
Hypertension
Post stroke
JNC7
2007 ESH-ESC guidelines
survey

Additional relevant MeSH terms:
Hypertension
Stroke
Vascular Diseases
Cardiovascular Diseases
 Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on May 16, 2013